SPONSOR

University of Zurich

Total Trials

Recruiting

Phases

Phase 1, Phase 2

Conditions studied: Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma CART Therapy Bispecific Antibody Geriatric Hematology Spinal Cord Injuries Pain, Neuropathic Nociceptive Pain Neuropathy Stroke Caregiver Burden

University of Zurich is a clinical research sponsor with 16 registered studies on ClinicalTrials.gov, of which 16 are actively recruiting participants. Research covers conditions including Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma, CART Therapy, Bispecific Antibody, Geriatric Hematology.

The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — University of Zurich

How many clinical trials has University of Zurich sponsored?

ClinicalMetric currently tracks 16 clinical trials sponsored by University of Zurich, of which 16 are actively recruiting participants. These trials cover conditions including Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma, CART Therapy, Bispecific Antibody. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does University of Zurich research focus on?

University of Zurich clinical trials span Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma, CART Therapy, Bispecific Antibody, Geriatric Hematology, Spinal Cord Injuries, and additional conditions. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a University of Zurich clinical trial?

To participate in a University of Zurich trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Zurich trials with current recruitment status updated daily.

University of Zurich

Frequently Asked Questions — University of Zurich

Clinical Trials by University of Zurich

Pragmatic Geriatric Assessment Before CAR-T or Bispecific Antibody Therapy to Predict Side Effects and Outcomes in Older Patients (GA-ACT Trial)

Pain Phenotyping in Patients With Neuropathic Pain After Spinal Cord Injury

Precision Sensorimotor Neurorehabilitation Through Personalized Stimulation Loops

Caregiver Stress and Bereavement

Auditory Sleep Stimulation or Sham in People With Parkinson Disease Mild Cognitive Impairment During Cognitive Training

Noninvasive Early Detection of Lung Allograft Dysfunction After Lung Transplantation With Multiple Breath Washout Test

Dose Escalation for SBRT of Recurrent VT Ventricular Tachyarrhythmia - a Single Center, Phase II Clinical Trial

Robotic-Assisted Versus Conventional Bronchoscopy for Cryobiopsy in the Diagnosis of Interstitial Lung Disease

Ex Vivo Drug Response Evaluation for Next Generation Care of Brain Metastases

Investigation of Brain Blood Flow Changes in Acute Ischemic Stroke Patients After Successful Endovascular Thrombectomy

The Acute Cardiorespiratory Response to Blood-flow Restricted Versus Traditional Exercise Training Regimens (CaRe BFR)

Natural Cervical Ripening to Prevent Pharmacological Induction of Labor - a Pilot Study.

International Multisite Transcatheter Tricuspid Valve Therapies Registry

Longitudinal Investigation of Brain Blood Flow Changes in Neurosurgical Patients

High-field MR Imaging in Migraine, Visual Snow and Epilepsy

Oral Propranolol for Prevention of Threshold Retinopathy of Prematurity